心脏麻醉中神经学评估与神经保护策略的现状调查
该调查由心血管麻醉医师协会(SCA)于2018年向其会员发放问卷,评估围术期神经保护策略的应用情况。共3645份邮件邀请,526名会员回复(14.4%)。结果显示多数受访者无标准化神经保护方案,约半数缺乏机构指南,可能影响术后神经预后。
要点
- 多数受访者(52.0%)报告其机构无标准化神经保护策略。
- 55.3%的受访者表示无机构指南指导术中或体外循环期间血压管理。
- 主动脉外膜超声和脑氧饱和度监测很少作为标准化监测方法(分别为1.9%和5.2%)。
核心结论
- 约半数SCA调查受访者未使用标准化指南或标准操作流程进行围术期脑保护。
研究设计与样本
- 由SCA持续实践改进-脑保护工作组的3名成员开发15项问卷,经工作组测试后于2018年3月26日至4月16日通过REDCap系统向3645名SCA会员发送,526人回复(14.4%)。
主要发现
- 58.3%的回复者来自学术机构,38.7%来自私人执业。
- 主动脉外膜超声最常应外科医生要求使用(46.5%)。
- 脑氧饱和度监测最常用于围术期脑损伤风险增加的患者(41.4%)。
- 主动脉外膜超声(1.9%)和脑氧饱和度(5.2%)很少作为标准化监测方法的一部分。
- 52.0%的回复者报告其机构无标准化神经保护管理策略。
关键数值与推荐
- 回复率14.4%(526/3645)。
- 主动脉外膜超声作为标准化监测的比例为1.9%。
- 脑氧饱和度作为标准化监测的比例为5.2%。
- 52.0%无标准化神经保护管理策略。
- 55.3%无标准化血压管理指南。
临床怎么用
- 调查提示心脏麻醉中神经保护策略的标准化程度较低,临床可参考此现状评估本机构实践。
局限性
- 回复率仅14.4%,可能存在无应答偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neurologic injury and cognitive disorder after cardiac surgery are associated with morbidity and mortality. Variability in the application of neuroprotective strategies likely exists during cardiac surgery. The Society of Cardiovascular Anesthesiologists (SCA) conducted a survey among its members on common perioperative neuroprotective strategies: assessment of aortic atheromatous burden, management of intraoperative blood pressure, and use of cerebral oximetry. METHODS: A 15-item survey was developed by 3 members of the SCA Continuous Practice Improvement - Cerebral Protection Working Group. The questionnaire was then circulated among all working group members, adapted, and tested for face validity. On March 26, 2018, the survey was sent to members of the SCA via e-mail using the Research Electronic Data Capture system. Responses were recorded until April 16, 2018. RESULTS: Of the 3645 surveys e-mailed, 526 members responded (14.4%). Most responders worked in academic institutions (58.3%), followed by private practices (38.7%). Epiaortic ultrasound for the assessment of aortic atheromatous burden was most commonly utilized at the surgeon's request (46.5%). Cerebral oximetry was most commonly used in patients with increased perioperative risk of cerebral injury (41.4%). Epiaortic ultrasound (1.9%) and cerebral oximetry (5.2%) were rarely part of a standardized monitoring approach. A majority of respondents (52.0%) reported no standardized management strategies for neuroprotection during cardiac surgery at their institution. A total of 55.3% stated that no standardized institutional guidelines were in place for managing a patient's blood pressure intraoperatively or during cardiopulmonary bypass. When asked about patients at risk for postoperative cerebral injury, 41.3% targeted a blood pressure goal >65 mmHg during cardiopulmonary bypass. The majority of responders (60.4%) who had access to institutional rates of postoperative stroke/cerebral injury had standard neuroprotective strategies in place. CONCLUSIONS: Our data indicate that approximately half of the respondents to this SCA survey do not use standardized guidelines/standard operating procedures for perioperative cerebral protection. The lack of standardized neuroprotective strategies during cardiac surgery may impact postoperative neurologic outcomes. Further investigations are warranted and should assess the association of standardized neuroprotective approaches and postoperative neurological outcomes.
引用
- Krause M, Morabito JE, Mackensen GB, et al. Current Neurologic Assessment and Neuroprotective Strategies in Cardiac Anesthesia: A Survey to the Membership of the Society of Cardiovascular Anesthesiologists. Anesth Analg. 2020. PMID: 31880633. doi:10.1213/ANE.0000000000004601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。